跳至主要内容

博文

目前显示的是标签为“Crystal Form”的博文

Preparation and Characterization of Two Polymorphs of (3aRS,4RS,7RS,7aSR)-2-(Tricyclo[3.3.1.13,7]decan-1-yl)-4,5,6,7-tetrahydro-4,7-eposyisoindoline-1,3-dione (SU2162) with PXRD and DSC

Read  full  paper  at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53119#.VLXOUMnQrzE Author(s) Wenfei Chen , Zaiyou Tan * , Lin Luo , Ruisi Yan , Hui Yang , Chunmei Tong , Yuqing Huang , Tingyu Huang , Yang Yang , Ruonan Wang Affiliation(s) School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China . ABSTRACT Objective: To develop the characterization of the polymorphs and the best preparation method of two forms of the title compound (SU2162). After SU2162 was prepared in accordance with the patent process, the crystal form I was recrystallized by ethyl acetate and the crystal form II was obtained by the recrystal in acetone. And the two crystal forms were characterized with differential scanning calorimetry (DSC) and X-ray powder diffraction (PXRD). The melting point of crystal form I (triclinic) is at 158°C, and the melting point of crystal form II (monoclinic) is at 163°C. The PXRD studies of the two crysta...